Your browser doesn't support javascript.
loading
Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection
Adam Hume; Mary Lou Beermann; Jonathan Lindstrom-Vautrin; Jake Le Suer; Jessie Huang; Judith Olejnik; Carlos Villacorta-Martin; Esther Bullitt; Anne Hinds; Mahboobe Ghaedi; Rhiannon Werder; Kristine Abo; Andrew Wilson; Elke Muhlberger; Darrell N. Kotton; Finn J Hawkins.
Afiliación
  • Adam Hume; Boston University
  • Mary Lou Beermann; Boston University
  • Jonathan Lindstrom-Vautrin; Boston University
  • Jake Le Suer; Boston University
  • Jessie Huang; Boston University
  • Judith Olejnik; Boston University
  • Carlos Villacorta-Martin; Boston University
  • Esther Bullitt; Boston University School of Medicine
  • Anne Hinds; Boston University
  • Mahboobe Ghaedi; Aztrazeneca
  • Rhiannon Werder; Boston University
  • Kristine Abo; Boston University School of Medicine
  • Andrew Wilson; Boston University
  • Elke Muhlberger; Boston University
  • Darrell N. Kotton; Boston University
  • Finn J Hawkins; Boston University
Preprint en En | PREPRINT-BIORXIV | ID: ppbiorxiv-451340
ABSTRACT
There is an urgent need to understand how SARS-CoV-2 infects the airway epithelium and in a subset of individuals leads to severe illness or death. Induced pluripotent stem cells (iPSCs) provide a near limitless supply of human cells that can be differentiated into cell types of interest, including airway epithelium, for disease modeling. We present a human iPSC-derived airway epithelial platform, composed of the major airway epithelial cell types, that is permissive to SARS-CoV-2 infection. Subsets of iPSC-airway cells express the SARS-CoV-2 entry factors ACE2 and TMPRSS2. Multiciliated cells are the primary initial target of SARS-CoV-2 infection. Upon infection with SARS-CoV-2, iPSC-airway cells generate robust interferon and inflammatory responses and treatment with remdesivir or camostat methylate causes a decrease in viral propagation and entry, respectively. In conclusion, iPSC-derived airway cells provide a physiologically relevant in vitro model system to interrogate the pathogenesis of, and develop treatment strategies for, COVID-19 pneumonia. Highlights and eTOC blurbO_LISubsets of human iPSC-airway epithelial cells express SARS-Co-V entry factors ACE2 and TMPRSS2. C_LIO_LIiPSC-airway cells are permissive to SARS-CoV-2 infection via multiciliated cells. C_LIO_LISARS-CoV-2 infection of iPSC-airway leads to a robust interferon and inflammatory response. C_LIO_LIiPSC-airway is a physiologically relevant model to study SARS-CoV-2 infection. C_LI
Licencia
cc_no
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-BIORXIV Idioma: En Año: 2021 Tipo del documento: Preprint
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-BIORXIV Idioma: En Año: 2021 Tipo del documento: Preprint